{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:56:55Z","timestamp":1791111415242,"version":"4.1.0"},"reference-count":486,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.freeradbiomed.2013.03.018","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T14:01:38Z","timestamp":1365256898000},"page":"1-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":383,"special_numbering":"C","title":["Mitochondrial Diseases of the Brain"],"prefix":"10.1016","volume":"63","author":[{"given":"Rajnish K.","family":"Chaturvedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Flint Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1471-4159.2006.03990.x","article-title":"The role of mitochondria in inherited neurodegenerative diseases","volume":"97","author":"Kwong","year":"2006","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM198505303122203","article-title":"The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP","volume":"312","author":"Burns","year":"1985","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","article-title":"Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease","volume":"100","author":"Sherer","year":"2007","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib8","article-title":"Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity","author":"Gash","year":"2007","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib9","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","article-title":"Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone","volume":"101","author":"Inden","year":"2007","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib11","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib12","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","article-title":"Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled","volume":"26","author":"Keeney","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib14","doi-asserted-by":"crossref","first-page":"42026","DOI":"10.1074\/jbc.M508628200","article-title":"Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication","volume":"280","author":"Panov","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/awl347","article-title":"Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?","volume":"130","author":"Lannuzel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","article-title":"Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe","volume":"88","author":"Champy","year":"2004","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-3-21","article-title":"Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells","volume":"3","author":"Borland","year":"2008","journal-title":"Molecular neurodegeneration"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib18","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1074\/jbc.M700827200","article-title":"Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain","volume":"282","author":"Castello","year":"2007","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2741\/2128","article-title":"Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome","volume":"12","author":"Gomez","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(89)90291-2","article-title":"Mitochondrial function in Parkinson's disease","volume":"2","author":"Bindoff","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson's disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.870120104","article-title":"Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study","volume":"12","author":"Itoh","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(91)90311-T","article-title":"Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease","volume":"104","author":"Bindoff","year":"1991","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Annals of neurology"},{"issue":"Pt 6","key":"10.1016\/j.freeradbiomed.2013.03.018_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/brain\/116.6.1451","article-title":"Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes","volume":"116","author":"Benecke","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mds.870130106","article-title":"Quantitative study of mitochondrial complex I in platelets of parkinsonian patients","volume":"13","author":"Blandini","year":"1998","journal-title":"Mov Disord"},{"issue":"Pt 2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/WNL.46.5.1343","article-title":"Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Grupo-Centro de Trastornos del Movimiento","volume":"46","author":"Martin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/0028-3886.28112","article-title":"Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: preliminary study","volume":"54","author":"Shinde","year":"2006","journal-title":"Neurol India"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257619","article-title":"Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease","volume":"4","author":"Yoshino","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(94)90248-8","article-title":"Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy","volume":"125","author":"Blin","year":"1994","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI43871","article-title":"Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients","volume":"121","author":"She","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.410350212","article-title":"An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease","volume":"35","author":"Mizuno","year":"1994","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0197-0186(02)00225-5","article-title":"Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease","volume":"43","author":"Gibson","year":"2003","journal-title":"Neurochemistry international"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410440207","article-title":"transmission of the mitochondrial defect in Parkinson's disease","volume":"44","author":"Gu","year":"1998","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson's disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/exnr.2001.7674","article-title":"Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects","volume":"169","author":"Swerdlow","year":"2001","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/bbrc.2000.4113","article-title":"Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLa cells restores complete mitochondrial respiratory function","volume":"280","author":"Aomi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.expneurol.2009.03.016","article-title":"The cybrid model of sporadic Parkinson's disease","volume":"218","author":"Trimmer","year":"2009","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.expneurol.2009.09.025","article-title":"Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships","volume":"220","author":"Keeney","year":"2009","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2008.09.014","article-title":"Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues","volume":"1792","author":"Borland","year":"2009","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1471-4159.2010.06631.x","article-title":"Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer","volume":"113","author":"Esteves","year":"2010","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mito.2008.03.004","article-title":"Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background","volume":"8","author":"Esteves","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.2000.7333","article-title":"Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines","volume":"162","author":"Trimmer","year":"2000","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/hum.2009.023","article-title":"Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model","volume":"20","author":"Keeney","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1999.tb07825.x","article-title":"Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease","volume":"893","author":"Ghosh","year":"1999","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib52","first-page":"659694","article-title":"Do somatic mitochondrial DNA mutations contribute to Parkinson's disease","volume":"2011","author":"Clark","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","article-title":"Mitochondrial disease","volume":"368","author":"Schapira","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","article-title":"Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases","volume":"55","author":"Chaturvedi","year":"2012","journal-title":"Molecular and cellular neurosciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib55","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pgen.0020128","article-title":"Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics","volume":"2","author":"Kazuno","year":"2006","journal-title":"PLoS genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12031-010-9488-9","article-title":"POLG1-related and other \"mitochondrial Parkinsonisms\": an overview","volume":"44","author":"Orsucci","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1479-7364-3-1-71","article-title":"sequence variation and neurodegeneration","volume":"3","author":"Mancuso","year":"2008","journal-title":"Hum Genomics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0197-4580(03)00037-X","article-title":"Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease","volume":"25","author":"Simon","year":"2004","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","article-title":"deletions\/rearrangements in parkinson disease and related neurodegenerative disorders","volume":"61","author":"Gu","year":"2002","journal-title":"Journal of neuropathology and experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0169-328X(94)00209-W","article-title":"Point mutations of mitochondrial genome in Parkinson's disease","volume":"28","author":"Ikebe","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/ana.23568","article-title":"Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body disease","volume":"71","author":"Lin","year":"2012","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.parkreldis.2010.09.007","article-title":"Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease","volume":"16","author":"Nishioka","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib63","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2004.11.093","article-title":"Mitochondrial ND5 mutations in idiopathic Parkinson's disease","volume":"326","author":"Parker","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.neurobiolaging.2004.02.020","article-title":"High frequency of mitochondrial complex I mutations in Parkinson's disease and aging","volume":"25","author":"Smigrodzki","year":"2004","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jnnp.71.5.685","article-title":"rearrangements in young onset parkinsonism: two case reports","volume":"71","author":"Siciliano","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib66","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib68","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00415-008-0892-9","article-title":"Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions","volume":"255","author":"Bender","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib69","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.wnl.0000276955.23735.eb","article-title":"polymerase gamma variants in idiopathic sporadic Parkinson disease","volume":"69","author":"Luoma","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib70","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib71","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/01.wnl.0000238963.07425.d5","article-title":"POLG1 in idiopathic Parkinson disease","volume":"67","author":"Tiangyou","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib72","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1212\/WNL.53.8.1787","article-title":"Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation","volume":"53","author":"Simon","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib73","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1093\/hmg\/ddq370","article-title":"Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis","volume":"19","author":"Burbulla","year":"2010","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib74","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00702-009-0273-2","article-title":"Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease","volume":"116","author":"De Mena","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib75","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib76","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.expneurol.2006.08.015","article-title":"Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease","volume":"203","author":"Liang","year":"2007","journal-title":"Experimental neurology"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib77","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"16","author":"Thomas","year":"2007","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib78","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib79","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","article-title":"alpha-Synuclein gene duplication is present in sporadic Parkinson disease","volume":"70","author":"Ahn","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib82","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archneur.65.4.514","article-title":"Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia","volume":"65","author":"Ikeuchi","year":"2008","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib83","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2008.05.005","article-title":"Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells","volume":"439","author":"Shavali","year":"2008","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib86","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib87","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","article-title":"Mitochondrial association of alpha-synuclein causes oxidative stress","volume":"65","author":"Parihar","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib88","doi-asserted-by":"crossref","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","article-title":"Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein","volume":"286","author":"Nakamura","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib89","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1074\/mcp.M700467-MCP200","article-title":"Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease","volume":"7","author":"Xun","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib90","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib91","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib92","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy","volume":"286","author":"Choubey","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib93","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nbd.2005.08.018","article-title":"Mice lacking alpha-synuclein are resistant to mitochondrial toxins","volume":"21","author":"Klivenyi","year":"2006","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib95","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","article-title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","volume":"6","author":"Klein","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0004.2011.01693.x","article-title":"Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease","volume":"82","author":"Kim","year":"2012","journal-title":"Clinical genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib97","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/11.22.2787","article-title":"Functional association of the parkin gene promoter with idiopathic Parkinson's disease","volume":"11","author":"West","year":"2002","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib98","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib99","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib100","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Garcia de Yebenes, J.; Mena, M. A. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib101","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/auto.5.5.8505","article-title":"Parkin-induced mitophagy in the pathogenesis of Parkinson disease","volume":"5","author":"Narendra","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1083\/jcb.201001039","article-title":"Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy","volume":"189","author":"Lee","year":"2010","journal-title":"The Journal of cell biology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib103","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.expneurol.2009.10.018","article-title":"PINK1 mutations and differential effects on mitochondrial function","volume":"221","author":"Tan","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib105","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/brain\/awl114","article-title":"PINK1 protein in normal human brain and Parkinson's disease","volume":"129","author":"Gandhi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib106","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2006.12.053","article-title":"Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease","volume":"414","author":"Abahuni","year":"2007","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib107","doi-asserted-by":"crossref","first-page":"e4597","DOI":"10.1371\/journal.pone.0004597","article-title":"PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease","volume":"4","author":"Liu","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib108","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbadis.2011.03.007","article-title":"PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons","volume":"1812","author":"Wang","year":"2011","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2007.07.010","article-title":"PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c","volume":"28","author":"Wang","year":"2007","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib110","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1471-4159.2009.05932.x","article-title":"Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux","volume":"108","author":"Marongiu","year":"2009","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib111","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddi377","article-title":"Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism","volume":"14","author":"Silvestri","year":"2005","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib112","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1073\/pnas.0705363105","article-title":"Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP","volume":"105","author":"Haque","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib113","doi-asserted-by":"crossref","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib114","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib115","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pbio.0050172","article-title":"PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1","volume":"5","author":"Pridgeon","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib116","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib117","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib118","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib119","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-4-23","article-title":"Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patients","volume":"4","author":"Nural","year":"2009","journal-title":"Molecular neurodegeneration"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/hmg\/ddq430","article-title":"DJ-1 acts in parallel to the PINK1\/parkin pathway to control mitochondrial function and autophagy","volume":"20","author":"Thomas","year":"2011","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib121","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1093\/hmg\/ddq288","article-title":"Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics","volume":"19","author":"Irrcher","year":"2010","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib122","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gene.2007.06.013","article-title":"Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits","volume":"400","author":"Lavara-Culebras","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib123","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib124","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","article-title":"Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice","volume":"16","author":"Yang","year":"2007","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib125","doi-asserted-by":"crossref","first-page":"e9367","DOI":"10.1371\/journal.pone.0009367","article-title":"Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1","volume":"5","author":"Krebiehl","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2009.10.025","article-title":"DJ-1 binds to mitochondrial complex I and maintains its activity","volume":"390","author":"Hayashi","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib127","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.0914876107","article-title":"DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway","volume":"107","author":"Aleyasin","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib128","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2","volume":"103","author":"Clements","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib129","doi-asserted-by":"crossref","first-page":"16535","DOI":"10.1073\/pnas.0508350102","article-title":"Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis","volume":"102","author":"Li","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib130","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib131","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1073\/pnas.0708452105","article-title":"A Drosophila model for LRRK2-linked parkinsonism","volume":"105","author":"Liu","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib132","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib133","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e3181ff9685","article-title":"Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2","volume":"75","author":"Mortiboys","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib135","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"Saha","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib136","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib137","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/humu.20713","article-title":"Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease","volume":"29","author":"Bogaerts","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib138","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1128\/MCB.24.22.9848-9862.2004","article-title":"Neuroprotective role of the Reaper-related serine protease HtrA2\/Omi revealed by targeted deletion in mice","volume":"24","author":"Martins","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib139","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yexcr.2010.01.005","article-title":"Modulation of mitochondrial function and morphology by interaction of Omi\/HtrA2 with the mitochondrial fusion factor OPA1","volume":"316","author":"Kieper","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib140","article-title":"The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease","author":"Van Laar","year":"2012","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib141","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.mito.2012.05.002","article-title":"Mitochondrial dynamics and neuronal fate in Parkinson's disease","volume":"12","author":"Santos","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2012.07809.x","article-title":"Leucine-Rich Repeat Kinase 2 (LRRK2) Disturbs Mitochondrial Dynamics via Dynamin-Like Protein (DLP1)","author":"Niu","year":"2012","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib143","unstructured":"Xie, W., Chung, K.K., Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease, Journal of neurochemistry, 10.1111\/j.1471-4159.2012.07769.x."},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib144","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib145","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1073\/pnas.0711845105","article-title":"Pink1 regulates mitochondrial dynamics through interaction with the fission\/fusion machinery","volume":"105","author":"Yang","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib146","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","article-title":"Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction","volume":"121","author":"Wang","year":"2012","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib147","doi-asserted-by":"crossref","first-page":"e1002537","DOI":"10.1371\/journal.pgen.1002537","article-title":"Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria","volume":"8","author":"Liu","year":"2012","journal-title":"PLoS genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib148","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","article-title":"Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction","volume":"121","author":"Wang","year":"2012","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib149","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddr235","article-title":"The PINK1\/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons","volume":"20","author":"Yu","year":"2011","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib150","doi-asserted-by":"crossref","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","article-title":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin","volume":"8","author":"Narendra","year":"2010","journal-title":"PLoS biology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib151","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","article-title":"PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility","volume":"147","author":"Wang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib152","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1073\/pnas.0913485107","article-title":"Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin","volume":"107","author":"Ziviani","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib153","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","article-title":"Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy","volume":"19","author":"Gegg","year":"2010","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib154","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nature cell biology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib155","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4161\/auto.6.8.13426","article-title":"p62\/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both","volume":"6","author":"Narendra","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib156","doi-asserted-by":"crossref","first-page":"40652","DOI":"10.1074\/jbc.M112.419721","article-title":"Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy","volume":"287","author":"Sun","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib157","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature10952","article-title":"Neurodegeneration: Trouble in the cell's powerhouse","volume":"483","author":"Narendra","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib158","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/ars.2010.3799","article-title":"Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control","volume":"14","author":"Narendra","year":"2011","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib159","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib161","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1427.027","article-title":"Mitochondrial approaches for neuroprotection","volume":"1147","author":"Chaturvedi","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib162","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib163","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archneur.1992.00530350075022","article-title":"Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease","volume":"49","author":"Grafton","year":"1992","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib164","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00870669","article-title":"Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease","volume":"241","author":"Kuwert","year":"1993","journal-title":"J Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib165","first-page":"1591","article-title":"Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study","volume":"42","author":"Feigin","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib166","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib167","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib168","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1007\/s11064-008-9855-x","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"33","author":"Schapira","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib169","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10863-010-9290-y","article-title":"Mitochondrial matters of the brain: the role in Huntington's disease","volume":"42","author":"Turner","year":"2010","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib171","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib172","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib173","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib174","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib175","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/hmg\/ddl248","article-title":"Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III","volume":"15","author":"Solans","year":"2006","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib176","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410430321","article-title":"Complex I defect in muscle from patients with Huntington's disease","volume":"43","author":"Arenas","year":"1998","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib177","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","article-title":"Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib178","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib179","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","article-title":"Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients","volume":"374","author":"Almeida","year":"2008","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib180","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1alpha function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib181","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib182","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mds.23258","article-title":"Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease","volume":"26","author":"Ciammola","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib183","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib184","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","article-title":"Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib185","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib186","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib187","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib188","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib189","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","article-title":"Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease","volume":"104","author":"Pandey","year":"2008","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","article-title":"Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway","volume":"13","author":"Ruan","year":"2004","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib191","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10571-007-9206-5","article-title":"Huntington's Disease and Mitochondrial DNA Deletions: Event or Regular Mechanism for Mutant Huntingtin Protein and CAG Repeats Expansion?!","volume":"27","author":"Banoei","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib192","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib193","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.45.10.1879","article-title":"Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients","volume":"45","author":"Horton","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib194","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-010-0589-2","article-title":"Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease","volume":"88","author":"Arning","year":"2010","journal-title":"J Mol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","article-title":"damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington's disease","volume":"8","author":"Acevedo-Torres","year":"2009","journal-title":"DNA Repair (Amst"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib196","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","article-title":"Mitochondrial-dependent apoptosis in Huntington's disease human cybrids","volume":"222","author":"Ferreira","year":"2010","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib197","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib198","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cne.21272","article-title":"Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease","volume":"501","author":"Petrasch-Parwez","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib199","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","article-title":"Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals","volume":"269","author":"Panov","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20754","article-title":"Low stability of Huntington muscle mitochondria against Ca2+ in R6\/2 mice","volume":"59","author":"Gizatullina","year":"2006","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib201","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib202","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib203","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib204","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib205","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib206","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib207","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib209","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib210","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","author":"Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib211","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","author":"Song","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib212","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nm0311-245","article-title":"Hugging tight in Huntington's","volume":"17","author":"Johri","year":"2011","journal-title":"Nature medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib214","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli","volume":"2","author":"Costa","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib215","article-title":"Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh((CAG)150) Huntington's disease knock-in mouse","author":"Bayram-Weston","year":"2011","journal-title":"Brain research bulletin"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib216","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00702-009-0328-4","article-title":"Abnormal morphology of peripheral cell tissues from patients with Huntington disease","volume":"117","author":"Squitieri","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib217","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib218","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib219","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib221","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib222","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib223","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib224","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation","volume":"30","author":"Cong","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib226","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib228","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib229","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1471-4159.2008.05388.x","article-title":"PPAR: a therapeutic target in Parkinson's disease","volume":"106","author":"Chaturvedi","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib231","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib232","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib233","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib234","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI27794","article-title":"PGC-1 coactivators: inducible regulators of energy metabolism in health and disease","volume":"116","author":"Finck","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib235","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib236","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-4-3","article-title":"The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease","volume":"4","author":"Weydt","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib237","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-4-10","article-title":"PGC-1alpha as modifier of onset age in Huntington disease","volume":"4","author":"Taherzadeh-Fard","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib238","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-6-32","article-title":"PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease","volume":"6","author":"Taherzadeh-Fard","year":"2011","journal-title":"Molecular neurodegeneration"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-1","article-title":"Portal, E.; Deyle, C.; Riess, O.; Nguyen, H. P. Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease","volume":"6","author":"Che","year":"2011","journal-title":"Molecular neurodegeneration"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"issue":"Suppl 2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib241","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib242","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000113689","article-title":"Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice","volume":"5","author":"Eckert","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib243","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib244","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/jcb.23062","article-title":"Effect of beta-amyloid (25-35) on mitochondrial function and expression of mitochondrial permeability transition pore proteins in rat hippocampal neurons","volume":"112","author":"Ren","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"The Journal of cell biology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib246","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J Neurosci"},{"issue":"Suppl 3","key":"10.1016\/j.freeradbiomed.2013.03.018_bib247","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/PL00014174","article-title":"In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease","volume":"249","author":"Rapoport","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib248","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib249","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.1996.0180","article-title":"Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease","volume":"142","author":"Chandrasekaran","year":"1996","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0925-4439(02)00222-3","article-title":"Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation","volume":"1637","author":"Huang","year":"2003","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib251","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib252","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1074\/jbc.M110.203018","article-title":"Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex","volume":"286","author":"Shi","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib253","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease","volume":"23","author":"Bosetti","year":"2002","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib254","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","article-title":"Cytochrome c oxidase is decreased in Alzheimer's disease platelets","volume":"25","author":"Cardoso","year":"2004","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib255","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1023\/A:1020783614031","article-title":"The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease","volume":"24","author":"Aksenov","year":"1999","journal-title":"Neurochem Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib256","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","article-title":"Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment","volume":"6","author":"Valla","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib257","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.44.6.1086","article-title":"Reduced platelet cytochrome c oxidase activity in Alzheimer's disease","volume":"44","author":"Parker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib258","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer's disease","volume":"59","author":"Kish","year":"1992","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib259","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(97)00741-6","article-title":"Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients","volume":"236","author":"Curti","year":"1997","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib260","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib261","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-8993(98)00248-0","article-title":"Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex","volume":"796","author":"Chandrasekaran","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib262","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2010.12.012","article-title":"Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease","volume":"74","author":"Chou","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib263","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-4159.2010.06615.x","article-title":"The amyloid precursor protein intracellular domain(AICD) disrupts actin dynamics and mitochondrial bioenergetics","volume":"113","author":"Ward","year":"2010","journal-title":"Journal of neurochemistry"},{"issue":"Suppl 2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib264","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","article-title":"Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice","volume":"20","author":"Dragicevic","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib265","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.4872","article-title":"Increased autophagic degradation of mitochondria in Alzheimer disease","volume":"3","author":"Moreira","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2011.04.006","article-title":"Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage","author":"Calkins","year":"2011","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib267","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Human molecular genetics"},{"issue":"Suppl 2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib268","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.3233\/JAD-2010-100666","article-title":"A synergistic dysfunction of mitochondrial fission\/fusion dynamics and mitophagy in Alzheimer's disease","volume":"20","author":"Santos","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib269","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease","volume":"20","author":"Calkins","year":"2011","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib270","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib271","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib272","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","article-title":"Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons","volume":"1812","author":"Calkins","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib273","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1111\/j.1582-4934.2009.00892.x","article-title":"Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis","volume":"13","author":"Pavlov","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib274","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib275","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4717-10.2011","article-title":"Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease","volume":"31","author":"Yao","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib276","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib277","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"Faseb J"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib278","doi-asserted-by":"crossref","first-page":"925050","DOI":"10.4061\/2011\/925050","article-title":"Amyloid-Beta interaction with mitochondria","volume":"2011","author":"Pagani","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib279","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000323264","article-title":"Further Evidence on Mitochondrial Targeting of beta-Amyloid and Specificity of beta-Amyloid-Induced Mitotoxicity in Neurons","volume":"8","author":"Tillement","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2003.11.068","article-title":"Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2\/Omi","volume":"357","author":"Park","year":"2004","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib281","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib282","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib283","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","article-title":"Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients","volume":"173","author":"Wang","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib284","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2003.09.011","article-title":"Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture","volume":"15","author":"Trimmer","year":"2004","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7","article-title":"Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways","volume":"48","author":"Khan","year":"2000","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib286","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/ars.2005.7.1101","article-title":"Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement","volume":"7","author":"Trimmer","year":"2005","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib287","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1471-4159.2004.02438.x","article-title":"Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity","volume":"89","author":"Cardoso","year":"2004","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib288","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neurobiolaging.2010.04.031","article-title":"Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort","volume":"31","author":"Lakatos","year":"2010","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib289","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1073\/pnas.0403649101","article-title":"Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication","volume":"101","author":"Coskun","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/JAD-2009-1156","article-title":"Heteroplasmy of mitochondrial D310 mononucleotide repeat region in the blood of patients with Alzheimer's disease","volume":"18","author":"Wang","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib291","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/elps.200500420","article-title":"Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism","volume":"27","author":"Hamblet","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib292","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0006-8993(00)03190-5","article-title":"Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease","volume":"893","author":"Qiu","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib293","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/hmg\/11.2.133","article-title":"High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain","volume":"11","author":"Lin","year":"2002","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib294","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.94.9.4526","article-title":"Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease","volume":"94","author":"Davis","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00439-005-0123-8","article-title":"Does the mitochondrial genome play a role in the etiology of Alzheimer's disease?","volume":"119","author":"Elson","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib296","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.brainres.2010.10.074","article-title":"Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese","volume":"1368","author":"Zhang","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib297","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2007.06.054","article-title":"The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population","volume":"264","author":"Liu","year":"2008","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib298","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2009.08.012","article-title":"Mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"1802","author":"Shi","year":"2010","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib299","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1073\/pnas.0912417107","article-title":"TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration","volume":"107","author":"Wils","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib300","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib301","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","article-title":"Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice","volume":"30","author":"Xu","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib302","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2007.09.038","article-title":"Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis","volume":"267","author":"Murata","year":"2008","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib303","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00415-009-5333-x","article-title":"Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process","volume":"257","author":"Isobe","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib304","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-004-0939-7","article-title":"Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene","volume":"109","author":"Sasaki","year":"2005","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(96)12314-4","article-title":"Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis","volume":"204","author":"Sasaki","year":"1996","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib306","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1471-4159.1998.71010281.x","article-title":"Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis","volume":"71","author":"Browne","year":"1998","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib307","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8","article-title":"Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death","volume":"46","author":"Borthwick","year":"1999","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib308","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00004728-198807000-00019","article-title":"Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study","volume":"12","author":"Hatazawa","year":"1988","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib309","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-004-0837-z","article-title":"Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene","volume":"107","author":"Sasaki","year":"2004","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib310","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1523\/JNEUROSCI.3829-04.2005","article-title":"Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice","volume":"25","author":"Kirkinezos","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib311","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0969-9961(03)00043-3","article-title":"Mitochondrial dysfunction due to mutant copper\/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine","volume":"13","author":"Beretta","year":"2003","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib312","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/11.17.2061","article-title":"Differential gene expression in a cell culture model of SOD1-related familial motor neurone disease","volume":"11","author":"Kirby","year":"2002","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib313","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","article-title":"Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn-superoxide dismutase mutant mice","volume":"96","author":"Damiano","year":"2006","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib314","doi-asserted-by":"crossref","first-page":"29626","DOI":"10.1074\/jbc.M203065200","article-title":"Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice","volume":"277","author":"Mattiazzi","year":"2002","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ceca.2011.02.004","article-title":"G37R SOD1 mutant alters mitochondrial complex I activity, Ca2+ uptake and ATP production","volume":"49","author":"Coussee","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib316","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/brain\/awf167","article-title":"Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis","volume":"125","author":"Menzies","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib317","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/00207454.2010.537416","article-title":"Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis","volume":"121","author":"Shrivastava","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib318","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01913123.2010.541985","article-title":"Ultrastructural variations in platelets and platelet mitochondria: a novel feature in amyotrophic lateral sclerosis","volume":"35","author":"Shrivastava","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib319","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneurol.2010.128","article-title":"Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis","volume":"67","author":"Crugnola","year":"2010","journal-title":"Archives of neurology"},{"issue":"Pt 7","key":"10.1016\/j.freeradbiomed.2013.03.018_bib320","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/brain\/123.7.1339","article-title":"abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis","volume":"123","author":"Vielhaber","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib321","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M109.041319","article-title":"Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis","volume":"285","author":"Zhou","year":"2010","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib322","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell metabolism"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib323","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2202-10-64","article-title":"Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease","volume":"10","author":"Jaiswal","year":"2009","journal-title":"BMC neuroscience"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib324","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib325","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1073\/pnas.0712209105","article-title":"Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria","volume":"105","author":"Vande Velde","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib326","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib327","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1523\/JNEUROSCI.4385-04.2005","article-title":"Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice","volume":"25","author":"Vijayvergiya","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib328","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/hmg\/ddn226","article-title":"Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria","volume":"17","author":"Kawamata","year":"2008","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib329","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","article-title":"An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria","volume":"14","author":"Wong","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib330","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","article-title":"Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1","volume":"18","author":"Kong","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib331","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1073\/pnas.0605814103","article-title":"Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials","volume":"103","author":"Ferri","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib332","doi-asserted-by":"crossref","first-page":"50966","DOI":"10.1074\/jbc.M209356200","article-title":"Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis","volume":"277","author":"Takeuchi","year":"2002","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib333","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1523\/JNEUROSCI.21-17-06569.2001","article-title":"Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis","volume":"21","author":"Guegan","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib334","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/ars.2009.2614","article-title":"Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS","volume":"11","author":"Sotelo-Silveira","year":"2009","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib335","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1460-9568.2006.04922.x","article-title":"Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1","volume":"24","author":"Raimondi","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib336","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/hmg\/ddq202","article-title":"ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2","volume":"19","author":"Pedrini","year":"2010","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib337","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","article-title":"Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content","volume":"16","author":"De Vos","year":"2007","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib338","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/ars.2009.2604","article-title":"Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis","volume":"11","author":"Magrane","year":"2009","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib339","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","article-title":"Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis","volume":"156","author":"Wiedemann","year":"1998","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(99)00236-1","article-title":"Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis","volume":"169","author":"Vielhaber","year":"1999","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib341","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-007-0299-1","article-title":"Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis","volume":"114","author":"Sasaki","year":"2007","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib342","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.410390210","article-title":"Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis","volume":"39","author":"Siklos","year":"1996","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib343","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/NEN.0b013e318275df4b","article-title":"Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS","volume":"71","author":"Thau","year":"2012","journal-title":"Journal of neuropathology and experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib344","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrneurol.2009.26","article-title":"Diagnosis and treatment of Friedreich ataxia: a European perspective","volume":"5","author":"Schulz","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"Rotig","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib346","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S0317167100006260","article-title":"Complex I and ATP content deficiency in lymphocytes from Friedreich's ataxia","volume":"36","author":"Heidari","year":"2009","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib347","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng0897-352","article-title":"Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue","volume":"16","author":"Wilson","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib348","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib349","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2008.01.010","article-title":"Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations","volume":"211","author":"Amiott","year":"2008","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib350","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1096\/fj.10-173609","article-title":"Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation","volume":"25","author":"Guillet","year":"2011","journal-title":"Faseb J"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib351","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/brain\/awq082","article-title":"Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A","volume":"133","author":"Cartoni","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib352","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10048-008-0166-9","article-title":"Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K","volume":"10","author":"Cassereau","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib353","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2010.09.006","article-title":"Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations","volume":"227","author":"Cassereau","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib354","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-4159.2005.03095.x","article-title":"Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport","volume":"93","author":"Perez-Olle","year":"2005","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib355","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","article-title":"Neuroprotective effects of creatine","volume":"40","author":"Beal","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib356","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12017-008-8053-y","article-title":"Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases","volume":"10","author":"Adhihetty","year":"2008","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib357","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exnr.1999.7049","article-title":"Creatine and cyclocreatine attenuate MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib358","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/JMN:21:3:191","article-title":"Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"21","author":"Klivenyi","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib359","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","article-title":"Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"88","author":"Klivenyi","year":"2004","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10476","article-title":"Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS","volume":"53","author":"Zhang","year":"2003","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib361","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nature medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib362","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib363","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2003","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib364","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib365","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases","volume":"109","author":"Yang","year":"2009","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib366","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib367","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000238518.34389.12","article-title":"Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial","volume":"67","author":"Bender","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib368","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nutres.2008.01.001","article-title":"Long-term creatine supplementation is safe in aged patients with Parkinson disease","volume":"28","author":"Bender","year":"2008","journal-title":"Nutr Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib369","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1545968306293449","article-title":"Juncos, J. L. Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial","volume":"21","author":"Hass","year":"2007","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib370","doi-asserted-by":"crossref","unstructured":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 66:664-671; 2006.","DOI":"10.1212\/01.wnl.0000201252.57661.e1"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib371","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","article-title":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results","volume":"31","author":"Investigators","year":"2008","journal-title":"Clinical neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib372","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1126\/science.315.5820.1778","article-title":"Clinical research. Testing a novel strategy against Parkinson's disease","volume":"315","author":"Couzin","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib373","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1016\/j.freeradbiomed.2013.03.018_bib374","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/ana.10479","article-title":"Bioenergetic approaches for neuroprotection in Parkinson's disease","volume":"53","author":"Beal","year":"2003","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib375","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-4886(95)90033-0","article-title":"Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity","volume":"132","author":"Schulz","year":"1995","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib376","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(97)01192-X","article-title":"Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice","volume":"783","author":"Beal","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib377","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib378","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Matthews","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib379","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib380","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib381","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib382","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib383","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2202-10-88","article-title":"Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10","volume":"10","author":"Somayajulu-Nitu","year":"2009","journal-title":"BMC neuroscience"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib384","doi-asserted-by":"crossref","first-page":"e33712","DOI":"10.1371\/journal.pone.0033712","article-title":"A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells","volume":"7","author":"Bergamini","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib385","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10495-006-8417-4","article-title":"Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells","volume":"11","author":"Naderi","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib386","first-page":"597","article-title":"Coenzyme Q10 effects in neurodegenerative disease","volume":"5","author":"Spindler","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib387","doi-asserted-by":"crossref","unstructured":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology 57:397\u2013404; 2001.","DOI":"10.1212\/WNL.57.3.397"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib388","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.50.3.793","article-title":"Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients","volume":"50","author":"Shults","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib389","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"Muller","year":"2003","journal-title":"Neuroscience letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib391","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneur.60.8.1170-b","article-title":"The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic","volume":"60","author":"Horstink","year":"2003","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib392","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00115-007-2285-1","article-title":"[Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?","volume":"78","author":"Storch","year":"2007","journal-title":"Nervenarzt"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib393","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch","year":"2007","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib394","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","article-title":"Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease","volume":"188","author":"Shults","year":"2004","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib395","doi-asserted-by":"crossref","unstructured":"NINDS-NETPD. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology 68:20\u201328; 2007.","DOI":"10.1212\/01.wnl.0000250355.28474.8e"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib396","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/01.wnl.0000187070.35365.d7","article-title":"Tolerance of high-dose (3,000 mg\/day) coenzyme Q10 in ALS","volume":"65","author":"Ferrante","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib397","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.21743","article-title":"Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III","volume":"66","author":"Kaufmann","year":"2009","journal-title":"Annals of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib398","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial","volume":"23","author":"Stamelou","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib399","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","article-title":"Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy","volume":"15","author":"Cooper","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib400","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0167-4943(92)90060-H","article-title":"Idebenone in senile dementia of Alzheimer type: a multicentre study","volume":"15","author":"Senin","year":"1992","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib401","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000119366","article-title":"A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease","volume":"36","author":"Weyer","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib402","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-7091-7508-8_30","article-title":"Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study","volume":"54","author":"Gutzmann","year":"1998","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib403","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2002-19833","article-title":"Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study","volume":"35","author":"Gutzmann","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib404","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","article-title":"Idebenone treatment fails to slow cognitive decline in Alzheimer's disease","volume":"61","author":"Thal","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib405","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib406","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.64.6.803","article-title":"Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia","volume":"64","author":"Di Prospero","year":"2007","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib407","article-title":"Mitochondria-Directed Therapeutics","author":"Armstrong","year":"2007","journal-title":"Antioxidants & redox signaling"},{"issue":"Suppl 2","key":"10.1016\/j.freeradbiomed.2013.03.018_bib408","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib409","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1096\/fj.05-3718com","article-title":"Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury","volume":"19","author":"Adlam","year":"2005","journal-title":"Faseb J"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib410","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"Faseb J"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib411","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1523\/JNEUROSCI.6566-10.2011","article-title":"Amyloid beta-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide","volume":"31","author":"Ma","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib412","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease","volume":"1832","author":"Solesio","year":"2013","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib413","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib414","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2007.1892","article-title":"Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury","volume":"10","author":"Szeto","year":"2008","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib415","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib416","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochemical pharmacology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib417","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-4159.2006.04018.x","article-title":"Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis","volume":"98","author":"Petri","year":"2006","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib418","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2009.2445","article-title":"Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity","volume":"11","author":"Yang","year":"2009","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib419","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib420","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-04-4539","article-title":"The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2\/ARE signaling","volume":"65","author":"Liby","year":"2005","journal-title":"Cancer research"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib421","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-06-0516","article-title":"Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes","volume":"6","author":"Yates","year":"2007","journal-title":"Molecular cancer therapeutics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib422","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib423","doi-asserted-by":"crossref","first-page":"e5757","DOI":"10.1371\/journal.pone.0005757","article-title":"Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription","volume":"4","author":"Yang","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib424","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/ars.2011.4491","article-title":"Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease","volume":"18","author":"Kaidery","year":"2013","journal-title":"Antioxidants & redox signaling"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib425","doi-asserted-by":"crossref","first-page":"37948","DOI":"10.1074\/jbc.M305204200","article-title":"NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons","volume":"278","author":"Lee","year":"2003","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib426","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1074\/jbc.M414635200","article-title":"Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo","volume":"280","author":"Shih","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib427","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","article-title":"Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis","volume":"51","author":"Neymotin","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib428","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib429","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1471-4159.2009.05970.x","article-title":"Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease","volume":"109","author":"Dumont","year":"2009","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib430","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington's disease","volume":"12","author":"Andreassen","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib431","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exnr.2001.7633","article-title":"Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice","volume":"168","author":"Andreassen","year":"2001","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib432","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1582-4934.2008.00390.x","article-title":"Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease","volume":"14","author":"Zhang","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib433","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib434","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Archives of neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2011-101356","article-title":"PPARgamma co-activator-1alpha (PGC-1alpha) reduces amyloid-beta generation through a PPARgamma-dependent mechanism","volume":"25","author":"Katsouri","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib436","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Science translational medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib437","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib438","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib439","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1073\/pnas.0800979105","article-title":"Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation","volume":"105","author":"Arany","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib440","doi-asserted-by":"crossref","first-page":"e35823","DOI":"10.1371\/journal.pone.0035823","article-title":"Diammonium glycyrrhizinate upregulates PGC-1alpha and protects against Abeta1-42-induced neurotoxicity","volume":"7","author":"Zhu","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib441","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1326-6-51","article-title":"Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis","volume":"6","author":"Zhao","year":"2012","journal-title":"Molecular neurodegeneration"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib442","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2012.03.019","article-title":"Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS","volume":"15","author":"Da Cruz","year":"2012","journal-title":"Cell metabolism"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib443","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Science translational medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib444","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","article-title":"PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease","volume":"45","author":"Chiang","year":"2012","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib445","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/hmg\/ddr541","article-title":"Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease","volume":"21","author":"Johri","year":"2012","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib446","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","article-title":"Rosiglitazone, a PPAR-gamma agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats","volume":"213","author":"Lee","year":"2012","journal-title":"Toxicology letters"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib447","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","article-title":"Differential susceptibility to the PPAR-gamma agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease","volume":"65","author":"Laloux","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib448","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-2012-111661","article-title":"Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease","volume":"30","author":"Searcy","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib449","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2008.12.071","article-title":"Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model","volume":"379","author":"Escribano","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib450","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Experimental neurology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib451","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2011.03.011","article-title":"Protective effect of pioglitazone, a PPARgamma ligand, in a 3 nitropropionic acid model of Huntington's disease","volume":"85","author":"Napolitano","year":"2011","journal-title":"Brain research bulletin"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib452","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2012.05.019","article-title":"Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington's disease","author":"Chen","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib453","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuropharm.2012.05.019","article-title":"Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington's disease","volume":"63","author":"Chen","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib454","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/hmg\/ddr618","article-title":"Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function","volume":"21","author":"Ciron","year":"2012","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib455","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/hmg\/dds178","article-title":"Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease","volume":"21","author":"Chaturvedi","year":"2012","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib456","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.molcel.2003.08.013","article-title":"TORCs: transducers of regulated CREB activity","volume":"12","author":"Conkright","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib457","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.0606714103","article-title":"Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells","volume":"103","author":"Wu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib458","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-2-21","article-title":"5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia","volume":"2","author":"Ayasolla","year":"2005","journal-title":"Journal of neuroinflammation"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib459","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2010.07.081","article-title":"Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis","volume":"399","author":"Won","year":"2010","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib460","doi-asserted-by":"crossref","first-page":"e24189","DOI":"10.1371\/journal.pone.0024189","article-title":"Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice","volume":"6","author":"Kaneb","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib461","doi-asserted-by":"crossref","first-page":"24460","DOI":"10.1074\/jbc.M112.382226","article-title":"trans-(-)-epsilon-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease","volume":"287","author":"Fu","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib462","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2010.06.020","article-title":"SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10","volume":"142","author":"Donmez","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib463","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib464","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"Embo J"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib465","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","article-title":"Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms","volume":"17","author":"Kumar","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib466","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib467","doi-asserted-by":"crossref","first-page":"21745","DOI":"10.1074\/jbc.M602909200","article-title":"Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction","volume":"281","author":"Qin","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib468","doi-asserted-by":"crossref","first-page":"40364","DOI":"10.1074\/jbc.M509329200","article-title":"SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling","volume":"280","author":"Chen","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib469","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochemistry international"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib470","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib471","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib472","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib473","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3727\/000000005783982756","article-title":"Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system","volume":"14","author":"Andres","year":"2005","journal-title":"Cell Transplant"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib474","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neuroscience.2005.03.004","article-title":"Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue","volume":"133","author":"Andres","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib475","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2008.08.004","article-title":"Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats","volume":"197","author":"Valastro","year":"2009","journal-title":"Behavioural brain research"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib476","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00188.x","article-title":"Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation","volume":"77","author":"Andreassen","year":"2001","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib477","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","article-title":"Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10","volume":"18","author":"Somayajulu","year":"2005","journal-title":"Neurobiology of disease"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib478","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.taap.2004.04.019","article-title":"Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10","volume":"201","author":"McCarthy","year":"2004","journal-title":"Toxicology and applied pharmacology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib479","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease","volume":"48","author":"Kasparova","year":"2006","journal-title":"Neurochemistry international"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2011.10.007","article-title":"Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease","volume":"49","author":"Hickey","year":"2012","journal-title":"Molecular and cellular neurosciences"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib481","doi-asserted-by":"crossref","first-page":"e9793","DOI":"10.1371\/journal.pone.0009793","article-title":"Comprehensive behavioral testing in the R6\/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline","volume":"5","author":"Menalled","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib482","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuro.2011.12.005","article-title":"Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway","volume":"33","author":"Choi","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib483","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2011-110209","article-title":"Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease","volume":"27","author":"Dumont","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib484","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12031-009-9297-1","article-title":"Coenzyme Q10 reduces beta-amyloid plaque in an APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"41","author":"Yang","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12031-007-9033-7","article-title":"Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation","volume":"34","author":"Yang","year":"2008","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.freeradbiomed.2013.03.018_bib486","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease","volume":"31","author":"McManus","year":"2011","journal-title":"J Neurosci"}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584913001238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584913001238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:11:07Z","timestamp":1760202667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584913001238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":486,"alternative-id":["S0891584913001238"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.03.018","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial Diseases of the Brain","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}